UniProt ID | CL16A_HUMAN | |
---|---|---|
UniProt AC | Q2KHT3 | |
Protein Name | Protein CLEC16A {ECO:0000305} | |
Gene Name | CLEC16A {ECO:0000312|HGNC:HGNC:29013} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1053 | |
Subcellular Localization |
Endosome membrane Peripheral membrane protein . Lysosome membrane Peripheral membrane protein . Associates with the endolysosome membrane. |
|
Protein Description | Regulator of mitophagy through the upstream regulation of the RNF41/NRDP1-PRKN pathway. Mitophagy is a selective form of autophagy necessary for mitochondrial quality control. The RNF41/NRDP1-PRKN pathway regulates autophagosome-lysosome fusion during late mitophagy. May protect RNF41/NRDP1 from proteosomal degradation, RNF41/NRDP1 which regulates proteosomal degradation of PRKN. Plays a key role in beta cells functions by regulating mitophagy/autophagy and mitochondrial health.. | |
Protein Sequence | MFGRSRSWVGGGHGKTSRNIHSLDHLKYLYHVLTKNTTVTEQNRNLLVETIRSITEILIWGDQNDSSVFDFFLEKNMFVFFLNILRQKSGRYVCVQLLQTLNILFENISHETSLYYLLSNNYVNSIIVHKFDFSDEEIMAYYISFLKTLSLKLNNHTVHFFYNEHTNDFALYTEAIKFFNHPESMVRIAVRTITLNVYKVSLDNQAMLHYIRDKTAVPYFSNLVWFIGSHVIELDDCVQTDEEHRNRGKLSDLVAEHLDHLHYLNDILIINCEFLNDVLTDHLLNRLFLPLYVYSLENQDKGGERPKISLPVSLYLLSQVFLIIHHAPLVNSLAEVILNGDLSEMYAKTEQDIQRSSAKPSIRCFIKPTETLERSLEMNKHKGKRRVQKRPNYKNVGEEEDEEKGPTEDAQEDAEKAKGTEGGSKGIKTSGESEEIEMVIMERSKLSELAASTSVQEQNTTDEEKSAAATCSESTQWSRPFLDMVYHALDSPDDDYHALFVLCLLYAMSHNKGMDPEKLERIQLPVPNAAEKTTYNHPLAERLIRIMNNAAQPDGKIRLATLELSCLLLKQQVLMSAGCIMKDVHLACLEGAREESVHLVRHFYKGEDIFLDMFEDEYRSMTMKPMNVEYLMMDASILLPPTGTPLTGIDFVKRLPCGDVEKTRRAIRVFFMLRSLSLQLRGEPETQLPLTREEDLIKTDDVLDLNNSDLIACTVITKDGGMVQRFLAVDIYQMSLVEPDVSRLGWGVVKFAGLLQDMQVTGVEDDSRALNITIHKPASSPHSKPFPILQATFIFSDHIRCIIAKQRLAKGRIQARRMKMQRIAALLDLPIQPTTEVLGFGLGSSTSTQHLPFRFYDQGRRGSSDPTVQRSVFASVDKVPGFAVAQCINQHSSPSLSSQSPPSASGSPSGSGSTSHCDSGGTSSSSTPSTAQSPADAPMSPELPKPHLPDQLVIVNETEADSKPSKNVARSAAVETASLSPSLVPARQPTISLLCEDTADTLSVESLTLVPPVDPHSLRSLTGMPPLSTPAAACTEPVGEEAACAEPVGTAED | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MFGRSRSWVGGG ---CCCCCCCCCCCC | 30.92 | 26657352 | |
7 | Phosphorylation | -MFGRSRSWVGGGHG -CCCCCCCCCCCCCC | 27.62 | 26657352 | |
15 | Ubiquitination | WVGGGHGKTSRNIHS CCCCCCCCCCCCCCH | 37.34 | - | |
35 | Malonylation | YLYHVLTKNTTVTEQ HHHHHHHCCCCCCHH | 48.40 | 26320211 | |
53 | Phosphorylation | LLVETIRSITEILIW HHHHHHHHHHEEEEE | 29.97 | - | |
144 | Phosphorylation | EIMAYYISFLKTLSL HHHHHHHHHHHHHHH | 14.38 | 24719451 | |
199 (in isoform 2) | Ubiquitination | - | 22.51 | - | |
356 | Phosphorylation | TEQDIQRSSAKPSIR HHHHHHHHHCCCCEE | 20.48 | 28555341 | |
357 | Ubiquitination | EQDIQRSSAKPSIRC HHHHHHHHCCCCEEE | 42.36 | 29967540 | |
357 | Phosphorylation | EQDIQRSSAKPSIRC HHHHHHHHCCCCEEE | 42.36 | 28555341 | |
359 | Ubiquitination | DIQRSSAKPSIRCFI HHHHHHCCCCEEEEE | 41.04 | 29967540 | |
365 (in isoform 2) | Ubiquitination | - | 6.05 | - | |
365 | Ubiquitination | AKPSIRCFIKPTETL CCCCEEEEECCCHHH | 6.05 | 29967540 | |
367 | Ubiquitination | PSIRCFIKPTETLER CCEEEEECCCHHHHH | 26.15 | 29967540 | |
371 | O-linked_Glycosylation | CFIKPTETLERSLEM EEECCCHHHHHHHHH | 36.08 | 23301498 | |
380 | Ubiquitination | ERSLEMNKHKGKRRV HHHHHHHCCCCHHCC | 45.44 | 24816145 | |
382 | Ubiquitination | SLEMNKHKGKRRVQK HHHHHCCCCHHCCCC | 68.67 | 24816145 | |
404 | Ubiquitination | GEEEDEEKGPTEDAQ CCHHHHCCCCCHHHH | 69.05 | - | |
420 | Phosphorylation | DAEKAKGTEGGSKGI HHHHHHCCCCCCCCC | 30.65 | - | |
427 | Ubiquitination | TEGGSKGIKTSGESE CCCCCCCCCCCCCCH | 5.17 | 21890473 | |
427 (in isoform 2) | Ubiquitination | - | 5.17 | 21890473 | |
429 | Phosphorylation | GGSKGIKTSGESEEI CCCCCCCCCCCCHHE | 39.79 | 30631047 | |
429 | Ubiquitination | GGSKGIKTSGESEEI CCCCCCCCCCCCHHE | 39.79 | 21890473 | |
430 | Phosphorylation | GSKGIKTSGESEEIE CCCCCCCCCCCHHEE | 35.25 | 30631047 | |
433 | Phosphorylation | GIKTSGESEEIEMVI CCCCCCCCHHEEEEE | 44.02 | 28348404 | |
443 | Ubiquitination | IEMVIMERSKLSELA EEEEEECHHHHHHHH | 23.01 | 21890473 | |
445 (in isoform 1) | Ubiquitination | - | 63.35 | 21890473 | |
445 | Ubiquitination | MVIMERSKLSELAAS EEEECHHHHHHHHHC | 63.35 | 23000965 | |
452 | Phosphorylation | KLSELAASTSVQEQN HHHHHHHCCCCCCCC | 18.66 | 26074081 | |
453 | Phosphorylation | LSELAASTSVQEQNT HHHHHHCCCCCCCCC | 28.34 | 26074081 | |
454 | Phosphorylation | SELAASTSVQEQNTT HHHHHCCCCCCCCCC | 21.22 | 26074081 | |
460 | Phosphorylation | TSVQEQNTTDEEKSA CCCCCCCCCHHHHHH | 35.01 | 26074081 | |
461 | Phosphorylation | SVQEQNTTDEEKSAA CCCCCCCCHHHHHHH | 49.30 | 26074081 | |
677 | Phosphorylation | FFMLRSLSLQLRGEP HHHHHHHHHHHCCCC | 18.47 | 23403867 | |
796 | Phosphorylation | LQATFIFSDHIRCII EEEEEECCCHHHHHH | 24.38 | 26091039 | |
834 | Phosphorylation | LDLPIQPTTEVLGFG HCCCCCCCCCEECCC | 21.15 | 22210691 | |
835 | Phosphorylation | DLPIQPTTEVLGFGL CCCCCCCCCEECCCC | 30.68 | 27251275 | |
844 | Phosphorylation | VLGFGLGSSTSTQHL EECCCCCCCCCCCCC | 35.17 | 27251275 | |
845 | Phosphorylation | LGFGLGSSTSTQHLP ECCCCCCCCCCCCCC | 25.28 | 33259812 | |
846 | Phosphorylation | GFGLGSSTSTQHLPF CCCCCCCCCCCCCCE | 37.17 | 27251275 | |
847 | Phosphorylation | FGLGSSTSTQHLPFR CCCCCCCCCCCCCEE | 28.19 | 22210691 | |
848 | Phosphorylation | GLGSSTSTQHLPFRF CCCCCCCCCCCCEEE | 21.79 | 22210691 | |
861 | Methylation | RFYDQGRRGSSDPTV EECCCCCCCCCCCCH | 57.05 | - | |
863 | Phosphorylation | YDQGRRGSSDPTVQR CCCCCCCCCCCCHHH | 29.74 | 28355574 | |
864 | Phosphorylation | DQGRRGSSDPTVQRS CCCCCCCCCCCHHHH | 50.89 | 25850435 | |
867 | Phosphorylation | RRGSSDPTVQRSVFA CCCCCCCCHHHHHEE | 33.97 | 25850435 | |
971 | Phosphorylation | PSKNVARSAAVETAS CCHHHHHHHHHHHHC | 15.73 | 23403867 | |
976 | Phosphorylation | ARSAAVETASLSPSL HHHHHHHHHCCCCCC | 18.23 | 23403867 | |
978 | Phosphorylation | SAAVETASLSPSLVP HHHHHHHCCCCCCCC | 36.48 | 29255136 | |
980 | Phosphorylation | AVETASLSPSLVPAR HHHHHCCCCCCCCCC | 15.22 | 29255136 | |
982 | Phosphorylation | ETASLSPSLVPARQP HHHCCCCCCCCCCCC | 38.33 | 29255136 | |
990 | Phosphorylation | LVPARQPTISLLCED CCCCCCCEEEEEECC | 18.17 | 20736484 | |
998 | Phosphorylation | ISLLCEDTADTLSVE EEEEECCCCCCCCEE | 12.25 | 28348404 | |
1001 | Phosphorylation | LCEDTADTLSVESLT EECCCCCCCCEEEEE | 20.61 | 28348404 | |
1003 | Phosphorylation | EDTADTLSVESLTLV CCCCCCCCEEEEEEC | 26.40 | 28348404 | |
1006 | Phosphorylation | ADTLSVESLTLVPPV CCCCCEEEEEECCCC | 25.21 | 28348404 | |
1008 | Phosphorylation | TLSVESLTLVPPVDP CCCEEEEEECCCCCH | 34.68 | 28348404 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CL16A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CL16A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CL16A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of CL16A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
222100 | Diabetes mellitus, insulin-dependent (IDDM) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...